Advertisement
Screener

PRA Health Sciences, Inc. Proceeds from Accounts Receivable Securitization

PRA Health Sciences, Inc. Proceeds from Accounts Receivable Securitization

PRA Health Sciences, Inc. reported Proceeds from Accounts Receivable Securitization of $42.50 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-24.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromAccountsReceivableSecuritization · last filed 2021-02-24

  • PRA Health Sciences, Inc. proceeds from accounts receivable securitization for the quarter ending 2016-06-30 was $0.00.
  • PRA Health Sciences, Inc. proceeds from accounts receivable securitization for the quarter ending 2016-03-31 was $120.00M.
  • PRA Health Sciences, Inc. proceeds from accounts receivable securitization for fiscal 2020 was $42.50M, a 41.67% increase from fiscal 2019.
  • PRA Health Sciences, Inc. proceeds from accounts receivable securitization for fiscal 2019 was $30.00M, a 50.00% decline from fiscal 2018.
  • PRA Health Sciences, Inc. proceeds from accounts receivable securitization for fiscal 2018 was $60.00M, a 200.00% increase from fiscal 2017.
  • PRA Health Sciences, Inc. proceeds from accounts receivable securitization for fiscal 2017 was $20.00M, a 83.33% decline from fiscal 2016.
Period endProceeds from Accounts Receivable Securitization 3 monthProceeds from Accounts Receivable Securitization 6 monthProceeds from Accounts Receivable Securitization 12 month
2020-12-31$42.50M
10-K · filed 2021-02-24
2019-12-31$30.00M
10-K · filed 2021-02-24
2018-12-31$60.00M
10-K · filed 2021-02-24
2017-12-31$20.00M
10-K · filed 2020-02-21
2017-06-30$20.00M
10-Q · filed 2017-08-08
2016-12-31$120.00M
10-K · filed 2019-02-28
2016-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$120.00M
10-Q · filed 2017-08-08
2016-03-31$120.00M
10-Q · filed 2017-04-26
2015-12-31$0.00
10-K · filed 2018-02-22